Lercanidipine Enhances Cisplatin Activity: Dual Anticancer and Anti-Inflammatory Effects via Caspase Activation and MAPK Inhibition
<b>Background/Objectives</b>: Lercanidipine is a third-generation dihydropyridine calcium channel blocker. In addition to their well-established cardiovascular effects, calcium channel blockers are increasingly recognized for their therapeutic potential in various cancers. This study aim...
Saved in:
| Main Authors: | Tugce Uskur, Sevde Nur Biltekin, Gokhan Faikoglu, Kubra Saygisever-Faikoglu, Barkın Berk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/5/651 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lercanidipine in arterial hypertension
by: C. Borghi
Published: (1970-01-01) -
LERCANIDIPINE IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: C. Beckey, et al.
Published: (2009-08-01) -
THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS
by: E. EL. Trisvetova
Published: (2015-09-01) -
OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE
by: E. L. Trisvetova
Published: (2015-09-01) -
LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: O. D. Ostroumova, et al.
Published: (2015-09-01)